Skip to main content
Internal Medicine Geriatrics and Gerontology

Geriatrics and Gerontology

Free for a limited time Dementia Review

Biomarkers for dementia with Lewy bodies

DLB remains underdiagnosed due to its clinical and pathological heterogeneity, but emerging diagnostic and prognostic biomarkers could herald a new age of precision medicine.

Hypotensive twilight zone in Parkinson’s disease

Free for a limited time Parkinson's Disease Case Study

Almost daily episodes of reduced responsiveness lasting up to an hour, with the patient slumped back in a chair but staying upright, indicated an under-recognised presentation of orthostatic hypertension.

Antipsychotic use in dementia has broad adverse outcomes

10-05-2024 Dementia News

Antipsychotic treatment of behavioral and psychological symptoms in patients with dementia is known to increase risk of stroke and death, but new findings indicate a broader range of adverse outcomes.

Update on managing RSV in older adults

A review of prevention and treatment strategies for respiratory syncytial virus infection in older adults, with a special focus on the novel vaccines now available.

What are the risk factors for PD?

Free for a limited time Parkinson's Disease Review

Explore the genetic, behavioral, and environmental factors that play a role in the pathogenesis and progression of Parkinson’s disease.

Webinar | 02-05-2024 | 17:30 (CEST)

Keynote webinar | Spotlight on sleep in brain health

Live event concluded

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

On-demand video coming soon

Dr. Rolf Fronczek
Dr. Renata Riha
Dr. Sven Rupprecht
Developed by: Springer Medicine

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Current Reviews

Definitions and adverse outcomes of sarcopenia in older patients in orthopedic and trauma care: A scoping review on current evidence

Open Access Sarcopenia Review Article

Sarcopenia is characterized by a decline of muscle mass and strength and is prevalent in 10–27% of individuals over 60 years old [ 1 ]. Despite the heightened interest in sarcopenia research, as illustrated by the annual increase of 18% in the …

Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis

Breast cancer is the leading cause of cancer-related mortality in women worldwide [ 1 , 2 ]. A diagnosis of breast cancer (stages I–III) leads a person into an unfolding sequence of treatments that include a combination of neoadjuvant chemotherapy …

Sarcopenia predicts postoperative complications in head and neck cancer: a systematic review and meta-analysis

Sarcopenia Review Article

Head and neck cancer (HNC) is one of the most common malignancies worldwide [ 1 ]. For patients with early stage or locoregionally advanced HNC, surgery is a curative treatment choice with or without postoperative (chemo)radiotherapy [ 2 ].

Immune Checkpoint Inhibitors in Geriatric Oncology

Cancer is widely considered a disease of aging. The care of older adults with cancer is complicated by factors such as frailty, multiple comorbidities, and age-related organ dysfunction [ 1 ]. These issues pose specific challenges to optimal …

Alzheimer's Disease Independent Medical Education

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by: Lilly

Developed by: Springer Healthcare IME

Case Studies

Hypotensive twilight zone in Parkinson’s disease

Free for a limited time Parkinson's Disease Case Study

Almost daily episodes of reduced responsiveness lasting up to an hour, with the patient slumped back in a chair but staying upright, indicated an under-recognised presentation of orthostatic hypertension.

Suspected ADHD in an older adult with bipolar disorder

Open Access Mental Health in Older People Case Study

Comorbid ADHD and bipolar disorder in older adults may go unrecognized and untreated, but this case shows that improved quality of life and functioning can be achieved safely with psychostimulant medications.

Unique presentation of memantine overdose

Open Access Medical Side Effect Case Study

Hypertensive urgency and echolalia were the most striking symptoms of memantine overdose in an elderly man with mild dementia and hypertension. Early medication review with caregivers of people with dementia is key.

News | Vodcasts | Podcasts (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Emerging biomarkers and disease-modifying therapies for Alzheimer’s disease promise significant changes in how the condition is diagnosed and managed.

Guide yourself through this transition with our education program, led by world renowned experts and covering the biggest international conferences.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Webcast | eLearning | Infographic (Link opens in a new window)

PET biomarkers are fast becoming critical in the new era of disease modification for Alzheimer’s disease. Techniques around amyloid and tau require the expertise of nuclear medicine and radiology physicians to investigate and interpret PET scans in clinical settings. This program examines current and emerging biomarkers and assists in identifying patterns from different PET tracers in an interactive perceptual learning environment.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Further Reading

Definitions and adverse outcomes of sarcopenia in older patients in orthopedic and trauma care: A scoping review on current evidence

Open Access Sarcopenia Review Article

Sarcopenia is characterized by a decline of muscle mass and strength and is prevalent in 10–27% of individuals over 60 years old [ 1 ]. Despite the heightened interest in sarcopenia research, as illustrated by the annual increase of 18% in the …

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

Open Access Sarcopenia Original Research

Sarcopenia may increase non-alcoholic fatty liver disease (NAFLD) risk, but prevalence likely varies with different diagnostic criteria. This study examined the prevalence of sarcopenia and its defining components in adults with and without NAFLD …

Evaluation of a new two-step frailty assessment of head and neck patients in a prospective cohort

Open Access Geriatric Assessment Head and Neck

The median age of the global population is rising, and consequently the median age of all cancer patients as well as of patients with head and neck cancer (HNC) [ 1 , 2 ]. Since HNC is the sixth most common malignancy worldwide and its incidence is …

Sarcopenic obesity and reduced BMD in young men living with HIV: body composition and sex steroids interplay

Open Access Sarcopenia Original Article

The clinical picture of men living with HIV (MLWH) has notably evolved thanks to the improvement in antiretroviral therapies (ART) [ 1 , 2 ]. As life expectancy in MLWH has increased [ 3 ], the clinical management of HIV has moved from the sole …

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu
Webinar | 08-11-2023 | 18:00 (CET)

Keynote webinar | Spotlight on diet and diabetes

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean
Prof. Falko Sniehotta
Developed by: Springer Medicine